You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 11, 2024

CLINICAL TRIALS PROFILE FOR TRICAPRILIN


✉ Email this page to a colleague

« Back to Dashboard


Clinical Trials for tricaprilin

Trial ID Title Status Sponsor Phase Summary
NCT00142805 ↗ Tricaprilin in Mild to Moderate Alzheimer's Disease Completed Accera, Inc. Phase 2 The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease.
NCT00142805 ↗ Tricaprilin in Mild to Moderate Alzheimer's Disease Completed Cerecin Phase 2 The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease.
NCT00355550 ↗ Tricaprilin In Age-Associated Memory Impairment Completed Accera, Inc. Phase 2 The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.
NCT00355550 ↗ Tricaprilin In Age-Associated Memory Impairment Completed Cerecin Phase 2 The purpose of this study is to determine whether tricaprilin, a compound that increases energy availability in the brain, improves memory in older adults with "normal" loss of memory abilities since early adult life.
NCT03551769 ↗ Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production Completed Accera, Inc. Phase 1 This is a Phase I, single center, open label, fixed-order, crossover, food-effect, pharmacokinetic (PK) study recruiting healthy, adult, male subjects.
NCT03551769 ↗ Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production Completed Cerecin Phase 1 This is a Phase I, single center, open label, fixed-order, crossover, food-effect, pharmacokinetic (PK) study recruiting healthy, adult, male subjects.
NCT03628352 ↗ Taste-masking Study for Tricaprilin in Sensory Panelists Completed Accera, Inc. Phase 1 This is an open-label multiple-dose study of the taste profile of tricaprilin formulated as a powder for reconstitution.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for tricaprilin

Condition Name

Condition Name
Intervention Trials
Alzheimer Disease 8
Alzheimer's Disease 2
Age-Associated Memory Impairment 1
Infantile Spasm 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH
Intervention Trials
Alzheimer Disease 10
Spasms, Infantile 1
Spasm 1
Migraine Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for tricaprilin

Trials by Country

Trials by Country
Location Trials
United States 11
Australia 7
Singapore 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State
Location Trials
Florida 3
Arizona 2
Massachusetts 1
Texas 1
Oregon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for tricaprilin

Clinical Trial Phase

Clinical Trial Phase
Clinical Trial Phase Trials
Phase 3 2
Phase 2 3
Phase 1 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status
Clinical Trial Phase Trials
Completed 6
Not yet recruiting 4
Recruiting 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for tricaprilin

Sponsor Name

Sponsor Name
Sponsor Trials
Cerecin 14
Accera, Inc. 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type
Sponsor Trials
Industry 19
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.